首页> 外文期刊>Epilepsia: Journal of the International League against Epilepsy >Rescue therapies for seizure emergencies: New modes of administration
【24h】

Rescue therapies for seizure emergencies: New modes of administration

机译:拯救紧急情况的救援疗法:新的行政方式

获取原文
获取原文并翻译 | 示例
       

摘要

A subgroup of patients with drug-resistant epilepsy have seizure clusters, which are a part of the continuum of seizure emergencies that includes prolonged episodes and status epilepticus. When the patient or caregiver can identify the beginning of a cluster, the condition is amenable to certain treatments, an approach known as rescue therapy. Intravenous drug administration offers the fastest onset of action, but this route is usually not an option because most seizure clusters occur outside of a medical facility. Alternate routes of administration have been used or are proposed including rectal, buccal, intrapulmonary, subcutaneous, intramuscular, and intranasal. The objective of this narrative review is to describe the (1) anatomical, physiologic, and drug physicochemical properties that need to be considered when developing therapies for seizure emergencies and (2) products currently in development. New therapies must consider parameters of Fick's law such as absorptive surface area, blood flow, membrane thickness, and lipid solubility, because these factors affect both rate and extend of absorption. For example, the lung has a 50000-fold greater absorptive surface area than that associated with a subcutaneous injection. Lipid solubility is a physicochemical property that influences the absorption rate of small molecule drugs. Among drugs currently used or under development for rescue therapy, allopregnanolone has the greatest lipid solubility at physiologic pH, followed by propofol, midazolam, diazepam, lorazepam, alprazolam, and brivaracetam. However, greater lipid solubility correlates with lower water solubility, complicating formulation of rescue therapies. One approach to overcoming poor aqueous solubility involves the use of a water-soluble prodrug coadministered with a converting enzyme, which is being explored for the intranasal delivery of diazepam. With advances in seizure prediction technology and the development of drug delivery systems that provide rapid onset of effect, rescue therapies may prevent the occurrence of seizures, thus greatly improving the management of epilepsy.
机译:耐药性癫痫患者的亚组具有癫痫发作簇,这是癫痫发作紧急情况连续的一部分,包括长期发作和地位癫痫症。当患者或护理人员可以识别簇的开始时,条件适用于某些治疗,一种称为救援治疗的方法。静脉内药物管理局提供最快的行动发作,但这条路线通常不是一种选择,因为大多数癫痫发作集群发生在医疗设施之外。已经使用或提出了包括直肠,口腔,血管癌,皮下,肌肉内和鼻内给药途径。该叙述审查的目的是描述在开发癫痫发作疗法和(2)产品的疗法时需要考虑的(1)解剖学,生理学和药物理化性质。新疗法必须考虑Fick的定律,如吸收表面积,血流,膜厚度和脂质溶解度,因为这些因素影响吸收的速率和延伸。例如,肺的吸收表面积比与皮下注射相关的更大吸收性表面积。脂质溶解度是一种物理化学性质,影响小分子药物的吸收率。在目前使用或正在开发的救援治疗的药物中,艾珀康酮在生理pH下具有最大的脂质溶解度,其次是异丙酚,咪达唑仑,Diazepam,Lorazepam,Alprazolam和Brivaracetam。然而,更大的脂质溶解度与较低的水溶解度相关,使救援疗法的制剂复杂化。克服差的水溶性的一种方法涉及使用具有转化酶的水溶性前药,其正在探索Diazexam的鼻内递送。随着癫痫发作预测技术的进步和提供快速发作效果的药物递送系统的发展,救援疗法可能会阻止癫痫发作的发生,从而大大改善了癫痫的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号